MoonLake holds Capital Markets Day; posts investor presentation on website

MoonLake Immunotherapeutics

Presentation posted September 11, 2023; covers financial position, near-term catalysts, and publication roadmap.
No specific financial figures or guidance changes disclosed in the filing.
Event is a routine investor update; no material news beyond the presentation content.

item 7.01 item 9.01

MoonLake Immunotherapeutics filing history →

Source: SEC EDGAR

accession 0001213900-23-075653

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.